- Home
- NAMS vs APLE Comparison
NAMS vs APLE Comparison
Compare NAMS & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- APLE
- Stock Information
- Founded
- NAMS 2019
- APLE 2007
- Country
- NAMS Netherlands
- APLE United States
- Employees
- NAMS N/A
- APLE N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- APLE Real Estate Investment Trusts
- Sector
- NAMS Health Care
- APLE Real Estate
- Exchange
- NAMS Nasdaq
- APLE Nasdaq
- Market Cap
- NAMS 3.1B
- APLE 2.9B
- IPO Year
- NAMS N/A
- APLE 2015
- Fundamental
- Price
- NAMS $32.86
- APLE $11.62
- Analyst Decision
- NAMS Strong Buy
- APLE Buy
- Analyst Count
- NAMS 9
- APLE 7
- Target Price
- NAMS $41.89
- APLE $14.71
- AVG Volume (30 Days)
- NAMS 974.1K
- APLE 2.7M
- Earning Date
- NAMS 11-05-2025
- APLE 11-03-2025
- Dividend Yield
- NAMS N/A
- APLE 8.29%
- EPS Growth
- NAMS N/A
- APLE N/A
- EPS
- NAMS N/A
- APLE 0.76
- Revenue
- NAMS $64,006,000.00
- APLE $1,423,951,000.00
- Revenue This Year
- NAMS N/A
- APLE $1.09
- Revenue Next Year
- NAMS $1.67
- APLE $2.21
- P/E Ratio
- NAMS N/A
- APLE $15.33
- Revenue Growth
- NAMS 762.15
- APLE 2.42
- 52 Week Low
- NAMS $14.06
- APLE $10.44
- 52 Week High
- NAMS $34.62
- APLE $16.50
- Technical
- Relative Strength Index (RSI)
- NAMS 72.18
- APLE 29.72
- Support Level
- NAMS $27.15
- APLE $11.91
- Resistance Level
- NAMS $34.59
- APLE $12.22
- Average True Range (ATR)
- NAMS 1.47
- APLE 0.20
- MACD
- NAMS 0.50
- APLE -0.07
- Stochastic Oscillator
- NAMS 73.37
- APLE 4.07
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.